All News

Dewayne Johnson, a patient with cancer who claimed that Monsanto’s Roundup product was at the root of his non-Hodgkin lymphoma diagnosis in 2014, was awarded $289 million by a jury, as reported by the Associated Press.

The Summer 2018 issue is out! And we have a sneak peek at what’s inside.

A cancer survivors take on comments regarding cancer.

Don't get stuck hanging out at the stop sign, advises a two-time cancer survivor.

It is not always easy to know what to say to a loved one who was just diagnosed with cancer. Here are some dos and don'ts that may help. But remember, every person is different.

The potential differences in the genetic risk factors among men and women for developing glioma may shed light on a new way to assess such risks, according to a meta-analysis published in Scientific Reports.

It's easy to identify with others who share our kind of cancer, but what about the rest?

It is possible after December 31, 2018, we may see a new way to reward wellness. Could this impact future cancer rates if we embrace a wellness mindset while also saving money?

After Barbara Demorest underwent a mastectomy, a silicone-based prosthetic seemed to be her only option, until her doctor asked a question that would change her life: “Do you knit?”

Lost homes, delayed treatments, death. Metastatic breast cancer patients have a shot at changing the access paradigm.

Understanding these outcomes is important in planning treatments and mitigating the possibility of patients stopping their treatment.

In a global analysis, researchers found global lung cancer mortality rates are projected to increase by 43 percent in women; however, breast cancer rates should decline by 9 percent.

How I leverage social media to raise testicular cancer awareness.

A new treatment has been approved to treat two rare forms of non-Hodgkin lymphoma.

Here are three main tips I wish I would have known during my first year of dealing with a cancer diagnosis.

The FDA has granted a breakthrough therapy designation to the combination of the BRAF inhibitor Braftovi (encorafenib), the MEK inhibitor Mektovi (binimetinib), and the EGFR inhibitor Erbitux (cetuximab) for the treatment of patients with BRAF V600E–mutant metastatic colorectal cancer (mCRC) following one or two prior lines of treatment in the metastatic setting.

Supporting people with cancer can have an added dimension when you are a survivor yourself. Here are three ways a survivor and caregiver can practice self care.

How a cancer patient still made great memories during one of the most challenging times of his life.

Patients who receive anti-PD-1 therapies may experience delayed cutaneous side effects like lesions, eczema or psoriasis, even after treatment has ended.

Chemotherapy treatment can greatly affect balance. But, there are things that can help.

Sometimes, you're ill prepared for a scan that might change the course of your life.

Clinical trials are starting to focus more on the tumor's genetic makeup than the tumor's location.

Learning to laugh during breast cancer takes practice, but with a little effort, it can become good medicine.

All the world's a stage, including cancer wards.

Surviving cancer includes balancing the fear of suffering with the prospect of surviving.

Am I getting old or is chemo brain coming back?

There is no easy way to gain a sense of control when dealing with cancer. And we all definitely deal with it differently.

The FDA has granted a breakthrough therapy designation to the combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) for the treatment of patients with advanced and/or metastatic non–microsatellite instability high (MSI-H)/proficient mismatch repair endometrial carcinoma who have progressed after at least one prior systemic therapy.

Coping with emotional and physical pain years after a spouse's death from cancer leads to more questions about his treatment.

Cognitive challenges that arise during the cancer journey can be frustrating. Researchers aim to learn more about the causes and treatment of ‘chemo brain.’